Five Prime Therapeutics, Inc.

๐Ÿ“ South San Francisco, United States๐Ÿ—“ Founded 2001๐Ÿ‘ฅ 134 employees๐Ÿ’ฐ Last funded 2006
Five Prime Therapeutics, Inc. (NASDAQ: FPRX) is a publicly traded, clinical-stage biotechnology company focused on discovering and developing innovative therapeutics to improve the lives of patients with serious diseases. Five Prime's comprehensive discovery platform, which encompasses virtually every medically relevant extracellular protein, positions it to explore pathways in cancer, inflammation and their intersection in immuno-oncology, an area with significant therapeutic potential and a growing focus of the company's R&D activities. Five Prime has entered into strategic collaborations with leading global pharmaceutical companies and has promising product candidates in clinical and late preclinical development. Five Prime is committed to innovation and outstanding science to develop effective new drugs for the treatment of severe diseases. We value our culture of openness, collaboration and productivity.
3
Total investors
2
Early stage
1
Mid stage
0
Late stage
2001
Founded
Investor geography1 country
United States
3
Investor activity2002โ€“2006 ยท investors recorded per year
200212003120061
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Five Prime Therapeutics, Inc.?
Five Prime Therapeutics, Inc. has 3 investors on record on gritt.io, including 2 early-stage backers, 1 mid-stage.
When did Five Prime Therapeutics, Inc. last raise funding?
The most recent investment in Five Prime Therapeutics, Inc. recorded on gritt.io was in 2006.
When was Five Prime Therapeutics, Inc. founded?
Five Prime Therapeutics, Inc. was founded in 2001.
What industry is Five Prime Therapeutics, Inc. in?
Five Prime Therapeutics, Inc. operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is Five Prime Therapeutics, Inc. based?
Five Prime Therapeutics, Inc. is headquartered in South San Francisco, United States.